Respiratory news

Additional tiotropium inhaler available to prescribe

Additional tiotropium inhaler available to prescribe

Acopair is delivered by the dry powder NeumoHaler device.

Fourth formoterol/budesonide dry powder inhaler launched

Fourth formoterol/budesonide dry powder inhaler launched

WockAIR is a further alternative to Symbicort Turbohaler.

New triple combination dry powder inhaler launched for COPD

New triple combination dry powder inhaler launched for COPD

Trimbow NEXThaler is a breath-actuated dry powder inhaler...

Sustainable inhaler prescribing incentive announced

Sustainable inhaler prescribing incentive announced

NHS England has introduced a new target for practices...

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

Luforbec 100/6 pressurised metered dose inhaler (pMDI)...

Third tiotropium inhaler adds to treatment options for COPD patients

Third tiotropium inhaler adds to treatment options for COPD patients

Tiogiva is a new breath-actuated inhaler containing...

MIMS supplement on asthma and COPD published

MIMS supplement on asthma and COPD published

The June issue of MIMS includes a MIMS+ supplement...

Fifth salmeterol/fluticasone dry powder inhaler launched

Fifth salmeterol/fluticasone dry powder inhaler launched

Fixkoh Airmaster is the fifth salmeterol/fluticasone...

Study links short-course oral steroids to severe adverse effects in children

Study links short-course oral steroids to severe adverse effects in children

Results from a recent study showed that use of a single...

Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care

Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care

Overuse of short-acting bronchodilator inhalers in...

Phyllocontin to be discontinued

Phyllocontin to be discontinued

Phyllocontin Continus 225mg and Phyllocontin Forte...

Third triple combination inhaler launched for COPD

Third triple combination inhaler launched for COPD

Trixeo Aerosphere is a new treatment for COPD patients,...

New LABA/LAMA combination inhaler increases choice for COPD patients

New LABA/LAMA combination inhaler increases choice for COPD patients

Bevespi Aerosphere (formoterol/glycopyrronium) is a...

First triple combination MDI licensed for asthma

First triple combination MDI licensed for asthma

Trimbow (beclometasone/formoterol/glycopyrronium) can...

New low-dose LABA/corticosteroid inhaler for asthma

New low-dose LABA/corticosteroid inhaler for asthma

A lower-dose metered-dose inhaler has been added to...

First 3-in-1 inhaler for asthma launched

First 3-in-1 inhaler for asthma launched

Enerzair Breezhaler is the first triple combination...

Consider bisphosphonates to combat osteoporosis risk in asthma patients taking steroids, say researchers

Consider bisphosphonates to combat osteoporosis risk in asthma patients taking steroids, say researchers

New research has linked oral and inhaled steroids to...

Honey 'more effective than antibiotics' for respiratory infections

Honey 'more effective than antibiotics' for respiratory infections

Honey is better than usual care for easing upper respiratory...

High prescribing of short-acting reliever inhalers 'suggests asthma guidance not being followed'

High prescribing of short-acting reliever inhalers 'suggests asthma guidance not being followed'

Frequent prescribing of short-acting ß2 agonists (SABA)...

Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits

Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits

Asthma guidelines recommend stepping down of medication...